Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03781570 · ClinicalTrials.gov registry record

Brain and Genetic Predictors of Individual Differences in Pain and Analgesia

A clinical trial, sponsored by Trustees of Dartmouth College.

Completed
Registry status
541
Enrollment target

NCT03781570 is a clinical trial that has completed, run by Trustees of Dartmouth College. The registered enrollment target is 541 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03781570 has completed, sponsored by Trustees of Dartmouth College.

COMPLETED
Registry status
541 participants
Enrollment target

Study Summary

The purpose of the study is to gain a better understanding of pain processing in the brain. Our understanding of how pain is processed in the brain is limited. We are testing for individual differences in pain perception and emotion.

Interventions

  • BEHAVIORAL Placebo Cream
  • BEHAVIORAL Control Cream

Trial Details

FieldValue
Enrollment Target 541 participants
Start Date 2018-11-07
Est. Completion 2023-10-01

Sponsor

Trustees of Dartmouth College

31 total trials

What the Registry Record Tells You About NCT03781570

The ClinicalTrials.gov registry entry for NCT03781570 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 541 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Trustees of Dartmouth College, which has 31 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo Cream is the first listed.

NCT03781570 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03781570 about?

NCT03781570 is a clinical study titled "Brain and Genetic Predictors of Individual Differences in Pain and Analgesia". The purpose of the study is to gain a better understanding of pain processing in the brain. Our understanding of how pain is processed in the brain is limited. We are testing for individual differences in pain perception and emotion.

What is the current status of trial NCT03781570?

This trial is currently completed. The enrollment target is 541 participants. The study started on 2018-11-07. Estimated completion is 2023-10-01.

What interventions are being tested in trial NCT03781570?

The interventions under investigation include: Placebo Cream (BEHAVIORAL), Control Cream (BEHAVIORAL).

Who is sponsoring clinical trial NCT03781570?

This trial is sponsored by Trustees of Dartmouth College, which has 31 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.